๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

[131] PHARMACOKINETICS OF TACROLIMUS AND MYCOPHENOLATE MOFETIL (MMF) IN LIVE DONOR AND DECEASED DONOR LIVER TRANSPLANT RECIPIENTS

โœ Scribed by A. Jain; R. Venkatramanan; T. Kwong; M. Orloff; P. Abt; R. Kashyap; G. Tsoulfas; C. Mack; P. Batzol; M. Williamson; A. Bozorgzadeh

Book ID
117375233
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
155 KB
Volume
46
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Comparison of pharmacokinetics of mycoph
Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients
โœ Shen Baiyong; Chen Bing; Zhang Weixia; Mao Huarong; Shen Chuan; Deng Xiaxing; Zh ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 236 KB

Living-donor liver transplantation (LDLT) has been considered an alternative method for treatment of patients with end-stage liver disease. However, the characteristics of pharmacokinetics of mycophenolic acid (MPA) in patients who underwent LDLT were not clear. This study was designed to compare th

Potential immunological advantage of int
Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction
โœ Ashokkumar Jain; Rajeev Sharma; Charlotte Ryan; Georgious Tsoulfas; Mark Orloff; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 102 KB

With the current immunosuppressive regimens, graft loss secondary to immunological reasons after successful liver transplantation is a rarity; acute rejections, however, do occur, with the majority of them being steroid-responsive. The aim of the present study is to examine the rate of acute rejecti

Pharmacokinetics of mycophenolate mofeti
Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
โœ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req